Mode
Text Size
Log in / Sign up
N/A N=360 Randomized Double-blind Supportive Care

Effects of Vitamin D on Moderate to Severe Periodontitis

Chronic Peritonitis

Enrolled (actual)
360
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcome: Primary: Attachment Loss (AL) — 4.7; 4.8; 4.8 mm — p=0.576

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
vitamin D (Dietary_supplement)
Age
Adult, Older Adult · 30+ yrs
Sex
All
Sponsor
Beijing Chao Yang Hospital
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Attachment Loss (AL)
3.4; 3.3; 3.3 0.042 sig
PRIMARY
Attachment Loss (AL)
3.4; 3.3; 3.3 0.042 sig
PRIMARY
Attachment Loss (AL)
3.4; 3.3; 3.3 0.042 sig
SECONDARY
Probing Depth (PD)
2.4; 2.5; 2.5 0.048 sig
SECONDARY
Probing Depth (PD)
2.4; 2.5; 2.5 0.048 sig
SECONDARY
Probing Depth (PD)
2.4; 2.5; 2.5 0.048 sig
SECONDARY
Alveolar Crest Height (ACH)
7.7; 7.7; 7.7 <0.05 sig
SECONDARY
Alveolar Crest Height (ACH)
7.7; 7.7; 7.7 <0.05 sig
SECONDARY
Alveolar Crest Height (ACH)
7.7; 7.7; 7.7 <0.05 sig
SECONDARY
Bleeding Index (BI)
0.9; 1.2; 1.1 0.075
SECONDARY
Bleeding Index (BI)
0.9; 1.2; 1.1 0.075
SECONDARY
Bleeding Index (BI)
0.9; 1.2; 1.1 0.075

Summary

The object of the study was to evaluate the direct effect of high dose vitamin D supplementation on chronic periodontitis, and suggest the recommended dose for clinic use.

Eligibility Criteria

Inclusion Criteria

  • Age from 30 years old to 70 years old
  • More than 20 teeth remaining in the mouth
  • Clinical diagnosis of moderate to severe periodontitis
  • Not receiving periodontal treatment within 6 months
  • Not taking antibiotic drugs within 3 months.

Exclusion Criteria

  • Diabetes, thyroid and parathyroid endocrine associated diseases
  • Severe systemic diseases, such as cancer
  • Taking vitamin D and / or calcium drugs during observation
  • Taking aspirin, non-steroidal anti-inflammatory drugs, and steroids
  • Pregnant or prepare to pregnant within one year
  • Have been suffering from hypercalcemia, malabsorption syndrome.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03044886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search